The Journal of Clinical Pharmacology · 2011 · 13 citations · 18 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyExercise TestingPulmonary Function TestingCardiac MedicationsCardiopulmonary Exercise TestingCardiovascular DiseaseCardiovascular Drug SafetyHypertension PharmacotherapyPulmonary Hypertension6-Minute Walk TestCardiac IndexDyspnea MeasurementFunctional Class AssessmentMulticenter TrialsPhosphodiesterase Type 5 Inhibitor TherapyPulmonary HemodynamicsVascular Resistance
The impact of sildenafil on pulmonary arterial hypertension (PAH) in Chinese patients has been less investigated. A prospective, open-label, uncontrolled and multicenter study, therefore, was carried out to address this issue. Ninety patients with multicause-induced PAH received oral sildenafil (75 mg/day) for 12 weeks. The 6-minute walk test (SMWT) and cardiac catheterization were performed at the beginning and the end of the 12 weeks. The primary endpoint was the changes in exercise capacity assessed by the SMWT; the secondary endpoint included assessment of functional class, evaluation of cardiopulmonary hemodynamics, and clinical worsening. Drug safety and tolerability were also examined. The results showed that there was a significant improvement in SMWT distances (342 ± 93 m vs 403 ± 88 m, P < .0001), Borg dyspnea score (2.9 ± 2.6 vs 2.4 ± 2.0, P = .0046), World Health Organization functional class, and cardiopulmonary hemodynamics (mean pulmonary artery pressure, P < .0001; cardiac index, P < .0001; pulmonary vascular resistance, P < .0001) after 12 weeks of oral sidenafil therapy. Almost all enrolled patients did not experience significant clinical worsening. This study confirms and extends the findings of previous studies relating to effects of sildenafil on PAH, suggesting that oral sildenafil is safe and effective for the treatment of adult patients with PAH in the Chinese population.
18
Bosentan Therapy for Pulmonary Arterial Hypertension
Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text
Shoichi Miyamoto, Noritoshi Nagaya, Toru Satoh et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 1.1K citations
Exercise Intolerance in Adult Congenital Heart Disease
Gerhard‐Paul Diller, Konstantinos Dimopoulos, Darlington O. Okonko et al. · Circulation · 2005 · 878 citations
Assessment of Survival in Patients With Primary Pulmonary Hypertension
Roland Wensel, Christian Opitz, Stefan D. Anker et al. · Circulation · 2002 · 568 citations · Full text